Table 1 Baseline characteristics of children enrolled in the trial
Characteristic | AL tablets N = 124 | AL suspension N = 121 | p |
|---|---|---|---|
Female sex (%) | 65 (52.4) | 58 (47.9) | 0.52 |
Prior anti-malarial use (2 months) N (%) | 3 (2.4) | 1 (0.8) | 0.62 |
ITN use N (%) | 55 (44.4) | 58 (47.9) | 0.49 |
Median age in months (+ SD) | 28 (16.3) | 25 (15.6) | 0.63 |
Mean weight in kg (+ SD) | 11.4 (3.3) | 11.7 (3.1) | 0.38 |
Mean temperature °C (+ SD) | 38.1 (1.2) | 38.2 (1.2) | 0.70 |
Mean* parasitaemia per μl (range) | 25,231 (2008 – 195288) | 34,881 (2111 – 196343) | 0.37 |
Mean haemoglobin g/dl (+ SD) | 9.5 (2.1) | 9.7 (1.9) | 0.38 |
Proportion with gametocytes N (%) | 14 (11.2) | 10 (8.2) | 0.42 |
Mean dose A/L mg (SD) | 124 (49)/871 (294) | 121 (40)/807 (239) | 0.06 |